Clinical Trials Browser

INDUSTRY × Expanded_access × Leukemia × Clear all

NCT05918913 2025-09-05

Expanded Access Program for Revumenib

No longer available

Other hematologic neoplasm

Leukemia, Recurrence

NCT03501615 2020-06-29

MOXE

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

NCT03114228 2019-10-15

An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)

No longer available

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute